| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | QL-XII-47 | GDSC1000 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | QL-VIII-58 | GDSC1000 | pan-cancer | AAC | 0.039 | 0.4 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.048 | 0.4 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | MS-275 | FIMM | pan-cancer | AAC | 0.11 | 0.4 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | 0.25 | 0.4 |
| mRNA | KIN001-260 | GDSC1000 | pan-cancer | AAC | -0.026 | 0.4 |
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | -0.027 | 0.4 |